[go: up one dir, main page]

AU2001289806A1 - Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations - Google Patents

Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations

Info

Publication number
AU2001289806A1
AU2001289806A1 AU2001289806A AU8980601A AU2001289806A1 AU 2001289806 A1 AU2001289806 A1 AU 2001289806A1 AU 2001289806 A AU2001289806 A AU 2001289806A AU 8980601 A AU8980601 A AU 8980601A AU 2001289806 A1 AU2001289806 A1 AU 2001289806A1
Authority
AU
Australia
Prior art keywords
mannosylglycerate
cosmetic
beta
derivatives
dermatological formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289806A
Inventor
Thomas Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bitop Gesellschaft fur Biotechnische Optimierung mbH
Original Assignee
BITOP GmbH
Bitop Gesellschaft fur Biotechnische Optimierung mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BITOP GmbH, Bitop Gesellschaft fur Biotechnische Optimierung mbH filed Critical BITOP GmbH
Publication of AU2001289806A1 publication Critical patent/AU2001289806A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001289806A 2000-08-18 2001-08-16 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations Abandoned AU2001289806A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040933 2000-08-18
DE10040933A DE10040933A1 (en) 2000-08-18 2000-08-18 Use of beta-mannosylglycerate (Firoin) and / or derivatives, in particular beta-mannosylglyceramide (Firoin-A), in cosmetic and dermatological formulations
PCT/EP2001/009445 WO2002015867A1 (en) 2000-08-18 2001-08-16 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations

Publications (1)

Publication Number Publication Date
AU2001289806A1 true AU2001289806A1 (en) 2002-03-04

Family

ID=7653225

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289806A Abandoned AU2001289806A1 (en) 2000-08-18 2001-08-16 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations

Country Status (6)

Country Link
US (1) US20050100534A1 (en)
EP (1) EP1311236A1 (en)
JP (1) JP2004506675A (en)
AU (1) AU2001289806A1 (en)
DE (1) DE10040933A1 (en)
WO (1) WO2002015867A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10330243A1 (en) * 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Use of osmolytes derived from extremophilic bacteria for the manufacture of medicines for the external treatment of atopic dermatitis
DE102004049062A1 (en) * 2004-03-30 2005-10-13 bitop Aktiengesellschaft für biotechnische Optimierung Topical preparation for application on the skin containing natural oil of the evening primrose (Oenothera biennis) (= Oleum Oenothera) and osmolytes from extremophilic microorganisms
EP1891854A1 (en) * 2006-08-21 2008-02-27 Shell Internationale Researchmaatschappij B.V. Process and composition for watering plants
DE102007040615A1 (en) * 2007-08-27 2009-03-05 Bitop Ag Osmolyte for the treatment of allergic or viral respiratory diseases
DE102007052380A1 (en) † 2007-10-31 2009-05-07 Bitop Ag Osmolyte-containing preparations for use in dry mucous membranes
JP5754796B2 (en) * 2010-07-26 2015-07-29 国立研究開発法人産業技術総合研究所 Antioxidants and their use
CN106093430A (en) * 2016-06-06 2016-11-09 上海阿趣生物科技有限公司 Can be used for mark detecting diabetes and application thereof
FR3061013B1 (en) * 2016-12-22 2020-04-17 Greenpharma COMPOSITION CONTAINING DIGENEASIDE, PROCESS FOR OBTAINING SAME AND ITS COSMETIC, VETERINARY OR NUTRACEUTICAL USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT101887A (en) * 1996-06-28 1998-01-30 Inst De Biolog Ex E Tecnologic USES OF 2-0-MANOSILGLICERATE FOR THERMOESTABILIZATION, OSMOPROTECTION AND PROTECTION AGAINST ENZYME DEHYDRATION, OTHER CELL COMPONENETES AND CELLS
EP1125583A1 (en) * 2000-02-14 2001-08-22 Bitop Gesellschaft für biotechnische Optimierung MbH Use of compatible solutes as inhibitors of the enzymatic degradation of macromolecular biopolymers
JP2003531833A (en) * 2000-04-12 2003-10-28 ビトプ アクチェンゲゼルシャフト フューア ビオテヒニシェ オプティミールング Use of compatible solutes as materials with free radical scavenging properties

Also Published As

Publication number Publication date
DE10040933A1 (en) 2002-03-07
EP1311236A1 (en) 2003-05-21
WO2002015867A1 (en) 2002-02-28
US20050100534A1 (en) 2005-05-12
JP2004506675A (en) 2004-03-04

Similar Documents

Publication Publication Date Title
AU2002215325A1 (en) Scalp cosmetic and dermatological compositions
AU2002212295A1 (en) Cosmetic and personal care compositions
AU2001295467A1 (en) Skin cosmetic formulations
AU2001296550A1 (en) Dermabrasion and skin care apparatus
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
AU2003210321A1 (en) Use of sugar esters in cosmetic and/or pharmaceutical preparations
SG72949A1 (en) Use of nanodispersions in cosmetic end formulations
AU2001269172A1 (en) Cosmetic and/or dermatological composition based on cocoa extracts
AU2001277501A1 (en) Cosmetic skin care compositions and containing gum mastic
AU2001233739A1 (en) Use of natural substances in the production of cosmetic preparations
AU3621500A (en) Urethane surfactants and their use in personal care formulations
AU6312501A (en) Skin care moisturizing and sunscreen compositions comprising organic particulatematerial
AU2002358653A1 (en) Cosmetic and/or pharmaceutical sunscreen preparations
AU7067200A (en) Skin care compositions and treatments
AU2001276440A1 (en) Use and cosmetic compositions of starch betainates
AU2002361060A1 (en) Use of apple core extracts in cosmetic or pharmaceutical compositions
AU1164601A (en) Therapeutic use and formulation
AU2001223722A1 (en) Use of microbially encapsulated materials in cosmetic end formulations
AU2001258381A1 (en) Use of parp inhibitors in cosmetic preparations
AU4117000A (en) Cosmetic product and its use
AU2002221792A1 (en) Cosmetic and personal care compositions containing cyclodextrins
AU2002347271A1 (en) Cosmetic composition for human skin and hair care
AU3270200A (en) Composition for cosmetic and dermatological skin care
AU2001289806A1 (en) Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations